Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies from Wake Forest University, Medical Department provide new data on breast cancer
November 6th, 2008
"Proliferative lesions of the mammary gland are risk markers and potential precursors for the development of breast cancer in postmenopausal women. In this study we evaluated mammary epithelial proliferation and proliferative lesions in a group of 63 aged postmenopausal macaques randomized by social group to receive one of three experimental diets for 8 months: ( 1) control; ( 2) control with 17b- estradiol ( E2) at the human equivalent dose of 1.0mg per day; and ( 3) control with the soy phytoestrogen equol ( EQ) at the human equivalent dose of 105mg per day," scientists in the United States report. "In normal mammary epithelium, treatment with E2 but not EQ resulted...
Source: Women's Health Weekly (2008-11-06)
|
